LIGAND PHARMACEUTICALS INC financial data

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1175% % -13%
Quick Ratio 27% % -63%
Debt-to-equity 36% % 178%
Return On Equity 14% %
Return On Assets 10% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19,941,141 shares 3.6%
Common Stock, Shares, Outstanding 19,774,000 shares 3.5%
Entity Public Float $1,600,000,000 USD 45%
Common Stock, Value, Issued $20,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 19,338,000 shares 5.7%
Weighted Average Number of Shares Outstanding, Diluted 20,294,000 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $268,087,000 USD 60%
Research and Development Expense $81,182,000 USD 279%
General and Administrative Expense $92,449,000 USD 18%
Operating Income (Loss) $41,002,000 USD
Nonoperating Income (Expense) $117,958,000 USD 370%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $158,960,000 USD 6213%
Income Tax Expense (Benefit) $34,507,000 USD 427%
Net Income (Loss) Attributable to Parent $124,453,000 USD
Earnings Per Share, Basic 6.44 USD/shares
Earnings Per Share, Diluted 6.13 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $174,927,000 USD 142%
Accounts Receivable, after Allowance for Credit Loss, Current $59,601,000 USD 55%
Inventory, Net $9,126,000 USD -35%
Other Assets, Current $5,785,000 USD -34%
Assets, Current $832,271,000 USD 151%
Deferred Income Tax Assets, Net $8,345,000 USD 11490%
Property, Plant and Equipment, Net $3,571,000 USD -76%
Operating Lease, Right-of-Use Asset $5,152,000 USD -25%
Intangible Assets, Net (Excluding Goodwill) $225,438,000 USD -15%
Goodwill $101,541,000 USD -3.5%
Other Assets, Noncurrent $12,582,000 USD -60%
Assets $1,560,637,000 USD 66%
Accounts Payable, Current $3,238,000 USD -38%
Employee-related Liabilities, Current $6,388,000 USD 16%
Accrued Liabilities, Current $31,453,000 USD 13%
Contract with Customer, Liability, Current $621,000 USD 0%
Liabilities, Current $37,447,000 USD 0.9%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Deferred Income Tax Liabilities, Net $36,019,000 USD 11%
Operating Lease, Liability, Noncurrent $4,204,000 USD -28%
Other Liabilities, Noncurrent $16,629,000 USD -45%
Liabilities $543,425,000 USD 388%
Accumulated Other Comprehensive Income (Loss), Net of Tax $8,455,000 USD
Retained Earnings (Accumulated Deficit) $608,088,000 USD 22%
Stockholders' Equity Attributable to Parent $1,017,212,000 USD 22%
Liabilities and Equity $1,560,637,000 USD 66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,445,000 USD -236%
Net Cash Provided by (Used in) Financing Activities $4,747,000 USD -139%
Net Cash Provided by (Used in) Investing Activities $4,894,000 USD
Common Stock, Shares Authorized 60,000,000 shares 0%
Common Stock, Shares, Issued 19,774,000 shares 3.5%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $27,139,000 USD -38%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $174,927,000 USD 142%
Interest Paid, Excluding Capitalized Interest, Operating Activities $97,000 USD 64%
Deferred Tax Assets, Valuation Allowance $48,331,000 USD -13%
Deferred Tax Assets, Gross $106,775,000 USD 11%
Operating Lease, Liability $5,301,000 USD -25%
Payments to Acquire Property, Plant, and Equipment $214,000 USD 104%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $138,850,000 USD
Lessee, Operating Lease, Liability, to be Paid $6,451,000 USD -32%
Property, Plant and Equipment, Gross $10,149,000 USD -57%
Operating Lease, Liability, Current $1,095,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,214,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,142,000 USD -26%
Operating Lease, Weighted Average Discount Rate, Percent 0.068 pure -9.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,150,000 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,124,000 USD -31%
Deferred Tax Assets, Operating Loss Carryforwards $32,514,000 USD -19%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $27,644,000 USD 23%
Lessee, Operating Lease, Liability, to be Paid, Year Four $886,000 USD -43%
Additional Paid in Capital $400,649,000 USD 19%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $8,770,000 USD 0.06%
Deferred Tax Assets, Net of Valuation Allowance $58,444,000 USD 44%
Interest Expense $557,000 USD -55%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%